Markets · delayed Markets · delayed · loading…
← Back to all news
Science GhanaBriefHealth Checked story Published 20 November 2026 · Updated 20 Nov, 11:32 UTC

Ghana will produce its first locally manufactured vaccine by 2027, Mahama says

President John Dramani Mahama says Ghana will produce its first locally manufactured vaccine by 2027, in a drive for vaccine self-sufficiency built on fill-and-finish manufacturing, the National Vaccine Institute and a stronger Food and Drugs Authority. He said clinical trials are critical to the plan, because locally made vaccines must be tested, proven safe and trusted by Ghanaians. The 2027 date is the president's projection, not an accomplished fact: no product or manufacturer was named in the reporting read.

President John Dramani Mahama at the Third Russia-Africa Summit in October 2026 (file photo)
Photo: Russian Presidential Executive Office via Wikimedia Commons (CC BY 4.0) · (File photo — not from this event)

Key points

  • Mahama: Ghana will produce its first locally manufactured vaccine by 2027 — his projection, stated as a national goal.
  • First phase is fill-and-finish manufacturing, built on the National Vaccine Institute, with the Food and Drugs Authority's regulation strengthened.
  • Clinical trials are critical, the president said: local vaccines must be proven safe and trusted, and he urged Ghanaians to take part in trials.
Show more (1)
  • No specific vaccine product or manufacturer was named in the reporting read.
Your take
Sign in to record your take — it’s free, so one person counts once
Takes sit on a free account, so one person counts once.

What happened

Ghana set up the National Vaccine Institute after COVID-19 exposed Africa's dependence on imported vaccines. Fill-and-finish — filling and packaging vaccine made from imported bulk — is the usual first step into local production, ahead of making the vaccine substance itself.

What we know / what we don't know yet

What we know

  • The president's 2027 goal and the shape of the plan — fill-and-finish first, the National Vaccine Institute, FDA strengthening — from his own remarks as reported by MyJoyOnline.
  • His insistence that clinical trials and public trust are central to the plan.

What we don't know yet

  • Which vaccine Ghana will produce first, and with which manufacturer — neither was named in the reporting read.
  • The production facility's current readiness and the plan's funding — neither was established in the reporting read.
§

Claim by claim

3 verified· 0 disputed· 0 not yet verified· 0 corrected
Show all claims (3)
Verified
President John Dramani Mahama said Ghana will produce its first locally manufactured vaccine by 2027, as part of a drive for vaccine self-sufficiency and health security. The plan centres on fill-and-finish manufacturing in the first phase, building on the National Vaccine Institute, with government support for local manufacturers, regulatory strengthening through the Food and Drugs Authority, and partnerships with international vaccine producers.

Why this label: Verified for the fact the president said it and set out that plan, in his own words as reported by MyJoyOnline; the 2027 production itself is a projection, carried as such throughout.

On the ladder: a claim earns Verified from primary evidence, or from two independent sources that do not copy each other.

Verified
Mahama said robust clinical trials are critical to vaccine self-sufficiency: locally manufactured vaccines must be tested, proven safe and effective, and trusted by Ghanaians. He called for stronger clinical-trial and regulatory systems and local scientific and manufacturing capacity, so Ghana can move from importing vaccines to producing and exporting them, and urged Ghanaians to join clinical trials.

Why this label: The president's own words on trials and trust, from MyJoyOnline's report of his remarks.

On the ladder: a claim earns Verified from primary evidence, or from two independent sources that do not copy each other.

Why it matters

A country that cannot make its own vaccines waits in line in a pandemic. Mahama's 2027 date is the first public deadline attached to Ghana's institute — whether a product, a facility and trials are in place to meet it is the test the deadline now sets.

Background

  • Africa depends on imported vaccines and waits behind producing countries — the experience Mahama cites as the drive's lesson.

  • Mahama sets 2027 for Ghana's first locally manufactured vaccine and puts clinical trials at the centre of the plan.

Update history

No silent edits. Every change is written here, with its time.

  • Latest

    Published — the president's statement is confirmed against MyJoyOnline's reports of his remarks; the 2027 date is carried as his projection.

← Back to all news